TEVA PHARMACEUTICAL INDUSTRIES LTD reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Tel Aviv
SEC filing record 1 source field available
Fiscal year end
31 December
TEVA PHARMACEUTICAL INDUSTRIES LTD has filed 2,535 SEC EDGAR filings since 02 Feb 1996

SEC filing history

Showing 76-92 of 92 matching filings.

Per page
25
Current page
4
8-K File 001-16174

TEVA PHARMACEUTICAL INDUSTRIES LTD. 8-K

Filing date
02 May 2019
Reporting date
02 May 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-16174

FORM 8-K

Filing date
10 Apr 2019
Reporting date
08 Apr 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-16174

TEVA PHARMACEUTICAL INDUSTRIES LIMITED 8-K

Filing date
13 Feb 2019
Reporting date
13 Feb 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-16174

FORM 8-K

Filing date
14 Dec 2018
Reporting date
14 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-16174

FORM 8-K

Filing date
04 Dec 2018
Reporting date
04 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-16174

TEVA PHARMACEUTICAL INDUSTRIES LIMITED 8-K

Filing date
26 Nov 2018
Reporting date
26 Nov 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-16174

TEVA PHARMACEUTICAL INDUSTRIES LIMITED 8-K

Filing date
01 Nov 2018
Reporting date
01 Nov 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-16174

TEVA PHARMACEUTICAL INDUSTRIES LIMITED 8-K

Filing date
02 Aug 2018
Reporting date
02 Aug 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-16174

FORM 8-K

Filing date
06 Jun 2018
Reporting date
05 Jun 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-16174

TEVA PHARMACEUTICAL INDUSTRIES LIMITED 8-K

Filing date
03 May 2018
Reporting date
03 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-16174

FORM 8-K

Filing date
27 Apr 2018
Reporting date
27 Apr 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-16174

FORM 8-K

Filing date
14 Mar 2018
Reporting date
14 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-16174

TEVA PHARMACEUTICAL INDUSTRIES LTD. 8-K

Filing date
08 Feb 2018
Reporting date
08 Feb 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-16174

FORM 8-K

Filing date
01 Feb 2018
Reporting date
01 Feb 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-16174

TEVA PHARMACEUTICAL INDUSTRIES LIMITED 8-K

Filing date
01 Feb 2018
Reporting date
01 Feb 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-16174

FORM 8-K

Filing date
04 Jan 2018
Reporting date
04 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-16174

8-K

Filing date
03 Jan 2018
Reporting date
02 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .